Gri Bio (GRI) Stock Performance Update
- Trading session: 24‑hour period ending 07:41 AM Central Europe, Thursday 22 September 2026.
- Price movement: Gri Bio shares increased by 0.68 %.
- Current price: Approximately USD 1.47 per share on major exchanges.
- Shares outstanding: 2.2 million.
- Market capitalization: USD 3.2 million.
- 24‑hour trading volume: Approximately USD 86.7 k worth of Gri Bio shares were traded.
- Monthly performance: Shares have fallen by 28.29 % since the end of the previous month.
- 200‑day simple moving average: USD 2.44.
- 52‑week range: Highest price USD 64.12 on 24 November 2025; lowest price USD 1.36 on 19 October 2026.
Recent Activity of Peer Companies
| Company | Symbol | 24‑hour change | Current price | Market capitalization |
|---|---|---|---|---|
| Hydrofarm | HYFM | -0.53 % | USD 0.75 | USD 3.6 million |
| Jupiter Neurosciences | JUNS | -0.71 % | USD 2.78 | USD 3.7 million |
| Expion Energy | XPON | +4.86 % | USD 4.10 | USD 3.8 million |
| Senestech | SNES | +8.85 % | USD 0.75 | USD 3.7 million |
| Aethlon Medical | AEMD | -4.52 % | USD 5.07 | USD 3.8 million |
Company Overview
Gri Bio, Inc. is a clinical‑stage biotechnology company headquartered in La Jolla, California. The company focuses on developing therapies that target natural killer T (NKT) immune cells to alter the course of inflammatory diseases. Gri Bio is listed on the Nasdaq stock exchange and serves patients in the United States. For more information, visit the company’s website at www.gribio.com .
